Abstract
The important contribution of the pulmonary vasculature to the expression of acute lung injury was recognized in early clinical and experimental studies of the syndrome of acute respiratory distress in adults (ARDS). Acute pulmonary hypertension was shown to be an important early feature with adverse prognostic implications, and persistence of the hypertension was found to be associated with structural vascular changes. More recently, it has been recognized that there is also a profound loss of pulmonary and systemic reactivity, with substantial implications for lung defense, gas exchange, etc.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kai, T. (1969) Distribution of adrenergic nerve fibers in the lungs of rabbit, guinea pig and man as demonstrated by Falck-Hillarp’s method. Bull. Chest Dis. Res.2, 225.
Partanen, M., Laitinen, A., Hervonen, A. et al. (1982) Catecholamine- and acteylcholinester-ase-containing nerves in human lower respiratory tract. Histochemistry, 76, 175–88.
Rudolph, A.M., Heyman, M.A. and Lewis, A.B. (1977) Physiology and pharmacology of the pulmonary circulation in the fetus and newborn, in Lung Biology in Health and Disease. Development of the Lung (ed. W.A. Hod-son), Marcel Dekker, New York, pp. 497–523.
Colebatch, H. J.H., Dawes, G.S., Goodwin, J.W. and Nadeau, R.A. (1965) The nervous control of the circulation in the foetal and newly expanded lungs of the lamb. J. Physiol., 178, 544–62.
Malik, A.B. and Kidd, L. (1973) Adrenergic blockade and the pulmonary vascular response to hypoxia. Respir. Physiol., 19, 96–106.
Kubota, E., Hamasaki, Y., Sata, T. et al. (1988) Autonomic innvervation of pulmonary artery: evidence for a nonadrenergic noncho-linergic inhibitory system. Exp. Lung Res., 14, 349–58.
Maggi, C.A., Patacchini, R., Perretti, F. et al. (1990) Sensory nerves, vascular endothelium and neurogenic relaxation of the guinea-pig isolated pulmonary artery. Naunyn Schmiedebergs Arch. Pharmacol., 342, 78–84.
Scott, J.A. and McCormack, D.G. (1993) Nitric oxide is a mediator of non-adrenergic, non-cholinergic vasodilation of human pulmonary arteries. Can. Fed. Biol. Soc., A243, 89.
Liu, S.F., Crawley, D.E., Evans, T.W. and Barnes, P. J. (1992) Endothelium dependent nonadrenergic, noncholinergic neural relaxation in guinea pig pulmonary artery. J. Pharmacol. Exp. Ther., 260, 541–8.
Barnes, P. J. (1986) Asthma as an axon reflex. Lancet, i: 242–5.
Palmer, R.M. J., Ferrige, A.G. and Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327, 524–6.
Ignarro, L. J., Buga, G.M., Wood, K.S. et al. (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sei. USA, 84, 9265–9.
Palmer, R.M. J., Ashton, D.S. and Moncada, S. (1988) Vascular endothelial cells synthesise nitric oxide from l-arginine. Nature, 333, 664–6.
Palmer, R.M. J., Rees, D.D., Ashton, D.S. and Moncada, S. (1988) l-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun., 153, 1251–6.
Rees, D.D., Palmer, R.M. J., Hodson, H.F. and Moncada, S. (1989) A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br. J. Pharmacol., 96, 418–24.
Persson, M.G., Gustafsson, L.E., Wiklund, N.P. et al. (1990) Endogenous nitric oxide as a modulator of rabbit skeletal muscle microcirculation in vivo. Br. J. Pharmacol., 100, 463–6.
Rees, D.D., Palmer, R.M. J., Schulz, R. et al. (1990) Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol., 101, 746–52.
Archer, S.L., Tolins, J.P., Raij, L. and Weir, E.K. (1989) Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. Biochem. and Biophys. Res. Commun., 164, 1198–205.
Persson, M.G., Gustafsson, L.E., Wiklund, N.P et al. (1990) Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo. Acta Physiol. Scand., 140, 449–57.
Greenberg, B., Rhoden, K. and Barnes, P. J. (1987) Endothelium-dependent relaxation of human pulmonary arteries. Am. J. Physiol., 252, H434–8.
Crawley, D.E., Liu, S.F., Evans, T.W. and Barnes, P. J. (1990) Inhibitory role of endothelium-derived relaxing factor in rat and human pulmonary arteries. Br. J. Pharmacol., 101, 166–70.
Beyne, J. (1942) Influence de l’anoxemie sur la grande circulation et sur la circulation pulmonaire. C.R. Soc. Biol. (Paris), 136, 399–400.
Marshall, C. and Marshall, B.E. (1983) Influence of perfusate Po 2 on hypoxic pulmonary vasoconstriction in rats. Circ. Res., 52, 691–6.
von Euler, U.S and Liljestrand, G. (1946) Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol. Scand., 12, 301–20.
Wagner, W.W. Jr, Latham, L.P. and Capen, R.L. (1979) Capillary recruitment during airway hypoxia: role of pulmonary artery pressure. J. Appl. Physiol., 47, 383–7.
Fishman, A.P., Fritts, H.W and Cournand, A. (1960) Effects of acute hypoxia and exercise on the pulmonary circulation. Circulation, 22, 204–15.
Silove, E.D. and Grover, R.F. (1968) Effects of alpha adrenergic blockade and tissue catecholamine depletion on pulmonary vascular response to hypoxia. J. Clin. Invest., 47, 274–85.
Lodato, R.F., Michael, J.R. and Murray, P.A. (1988) Absence of neural modulation of hypoxic pulmonary vasoconstriction in conscious dogs. J. Appl. Physiol., 65, 1481–7.
Peake, M.D., Harabin, A.L., Brennan, N. J. and Sylvester, J.T. (1981) Steady-state vascular responses to graded hypoxia in isolated lungs of five species. J. Appl. Physiol., 51, 1214–9.
Robin, E.D., Theodore, J., Burke, C.M. et al. (1987) Hypoxic pulmonary vasoconstriction persists in the human transplanted lung. Clin. Sei., 72, 283–7.
Kato, M. and Staub, N.C. (1966) Response of small pulmonary arteries to unilobar hypoxia and hypercapnia. Circ. Res., 19, 426–40.
Hakim, T.S., Michel, R.P., Minami, H. and Chang, H.K. (1983) Site of pulmonary hypoxic vasoconstriction studied with arterial and venous occlusion. J. Appl. Physiol., 54, 1298–302.
Nagasaka, Y., Bhattacharya, J., Nanjo, S. et al. (1984) Micropuncture measurement of lung microvascular pressure profile during hypoxia in cats. Cir. Res., 54, 90–5.
Shirai, M., Sada, K. and Ninomiya, I. (1986) Effects of regional alveolar hypoxia and hypercapnia on small pulmonary vessels in cats. J. Appl. Physiol., 61, 440–8.
Miller, D., Hamilton, J.T. and Paterson, N.A.M. (1989) The role of leukotrienes in hypoxic contractions of isolated porcine pulmonary artery and vein. Exp. Lung Res., 15, 213–22.
Raj, J.V. and Chen, P. (1986) Micropuncture measurement of microvascular pressures in isolated lamb lungs during hypoxia. Cir. Res., 59, 398–404.
Paterson, N.A.M., Hamilton, J.T., Yaghi, A. et al. (1988) ERffect of hypoxia on responses of respiratory smooth muscle to histamine and LTD4. J. Appl. Physiol., 64, 435–40.
Lloyd, T.C. (1968) Hypoxic pulmonary vasoconstriction: role of perivascular tissue. J. Appl. Physiol., 25, 560–5.
Cutaia, M. and Rounds, S. (1990) Hypoxic pulmonary vasoconstriction: physiological significance, mechanism, and clinical relevance. Chest, 97, 706–18.
Fishman, A.P (1985) Pulmonary circulation, in Handbook of Physiology, (ed. S.R. Geiger), American Physiological Society, Bethesda, M.D., pp. 93–165.
Stenmark, K.R., James, S. J., Voelkel, N. et al. (1983) Leukotriene C4 and D4 in neonates with hypoxemia and pulmonary hypertension. N. Engl. J. Med., 309, 77–80.
Morganroth, M.L., Stenmark, K.R., Zirrolli, J.A. et al. (1984) Leukotriene C4 production during hypoxic pulmonary vasoconstriction in isolated rat lungs. Prostaglandins, 28, 867–5.
Morganroth, M.L., Stenmark, K.R., Morris, K.G. et al. (1985) Diethylcarbamazine inhibits acute and chronic hypoxic vasoconstriction in awake rats. Am. Rev. Respir. Dis., 131, 488–92.
Goldberg, R.N., Suguihara, C., Ahmed, T. et al. (1985) Influence of an antagonist of slow-reacting substance of anaphylaxis on the cardiovascular manifestations of hypoxia in piglets. Pediatr. Res., 19, 1201–5.
Raj, J.U. and Chen, P. (1987) Role of eicosa-noids in hypoxic vasoconstriction in isolated lamb lungs. Am. J. Physiol., 253, H626–33.
Schreiber, M.D., Heymann, M.A. and Soifer, S. J. (1985) Leukotriene inhibition prevents and reverses hypoxic pulmonary vasoconstriction in newborn lambs. Pediatr. Res., 19, 437–41.
Voelkel, N.F., Stenmark, K.R., Reeves, J.T. et al. (1984) Actions of lipoxygenase metabolites in isolated rat lungs. J. Appl. Physiol., 57, 860–7.
Schnaar, R.L. and Sparks, H.V. (1972) Response of large and small coronary arteries to nitroglycerine, NaNO2, and adenosine. Am. J. Physiol., 223, 223–8.
Gottlieb, J.E., McGeady, M. Adkinson, N.F. Jr and Sylvester, J.T. (1988) Effects of cycloand lipoxygenase inhibitors on hypoxic vasoconstriction in isolated ferret lungs. J. Appl. Physiol., 64, 936–43.
Lonigro, A. J., Sprague, R.S., Stephenson, A.H. and Dahms, T.E. (1988) Relationship of leuko-triene C4 and D4 to hypoxic pulmonary vasoconstriction. J. Appl. Physiol., 64, 2538–43.
Leffler, C.W., Mitchell, J.A. and Green, R.S. (1984) Cardiovascular effects of leukotrienes in neonatal piglets. Cir. Res., 55, 780–7.
Garrett, R.C., Foster, S. and Thomas, H.M. III. (1987) Lipoxygenase and cyclooxygenase blockade by BW 755c enhances pulmonary hypoxic vasoconstriction. J. Appl. Physiol., 62, 129–33.
Rubin, L. J., Hughes, J.D. and Lazar, J.D. (1985) The effects of eicosanoid synthesis inhibitors on normoxic and hypoxic pulmonary vascular tone. Am. Rev. Respir. Dis., 132, 93–8.
Schuster, D.P. and Dennis, D.R. (1987) Leukotriene inhibitors do not block hypoxic pulmonary vasoconstriction in dogs. J. Appl. Physiol., 62, 1808–13.
McCormack, D.G. and Paterson, N.A.M. (1989) The contrasting influence of two lipoxygenase inhibitors on hypoxic pulmonary vasoconstriction in anesthetized pigs. Am. Rev. Respir. Dis., 139, 100–5.
Thomas, H.M. III, Sourour, M.S., Lopez, D. and Foster, S.H. (1989) Antagonism of leuko-triene receptors and administration of a 5-lipoxygenase inhibitor do not affect hypoxic vasoconstriction. Lung, 167, 187–98.
Cassin, S., Gause, G., Davis, T. et al. (1989) Do inhibitors of lipoxygenase and cycloxygenase block neonatal pulmonary vasoconstriction? J. Appl. Physiol., 66, 1779–884.
Kourembanas, S., Marsden, P.A., McQuillan, L.P. and Faller, D.V. (1991) Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J. Clin. Invest., 88, 1054–7.
De Mey, J.G. and Vanhoutte, P.M. (1983) Anoxia and endothelium-dependent reactivity of the canine femoral artery. J. Physiol. (Lond.), 335, 65–74.
Muramatsu, M., Iwama, Y., Shimizu, K. et al. (1992) Hypoxia-elicited contraction of aorta and coronary artery via removal of endothe-lium-derived nitric oxide. J. Appl. Physiol., 263, H1339–47.
Holden, W.E. and McCall, E. (1984) Hypoxia-induced contractions of porcine pulmonary artery strips depend on intact endothelium. Exp. Lung Res., 7, 101–12.
Rodman, D.M., Yamaguchi, T., O’Brien, R.F. and McMurtry, I.F. (1988) Hypoxic contraction of isolated rat pulmonary artery. J. Pharmacol. Exp. Ther., 248, 952–9.
Demiryurek, A.T., Wadsworth, R.M., Kane, K.A. and Peacock, A. J. (1993) The role of endothelium in hypoxic constriction of human pulmonary artery rings. Am. Rev. Respir. Dis., 147, 283–90.
Zhao, Y., Packer, C.S. and Rhoades, R.A. (1992) Pulmonary vein contracts in response to hypoxia. Am. J. Physiol., 265, L87–92.
Ohe, M., Ogata, M., Katayose, D. and Takish-ima, T. (1992) Hypoxic contraction of pre-stretched human pulmonary artery. Respir. Physiol., 87, L05–14.
Ogata, M., Ohe, M., Katayose, D. and Takish-ima, T. (1992) Modulatory role of EDRF in hypoxic contraction of isolated porcine pulmonary arteries. Am. J. Physiol., 262, H691–7.
Yuan, X.-J., Tod, M.L., Rubin, L. J. and Blaustein, M.P. (1990) Contrasting effects of hypoxia on tension in rat pulmonary and mesenteric arteries. Am. J. Physiol., 259, H281–9.
Weir, E.K. (1978) Does normoxic pulmonary vasodilatation rather than hypoxic vasoconstriction account for the pulmonary pressor response to hypoxia? Lancet, i, 476–7.
Rodman, D.M., Yamaguchi, T., Hasunuma, K. et al. (1990) Effects of hypoxia on endothe-lium-dependent relaxation of rat pulmonary artery. Am. J. Physiol., 258, L207–14.
Johns, R.A., Linden, J.M. and Peach, M. J. (1989) Endothelium-dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia. Circ. Res., 65, 1508–15.
McCormack, D.G. and Paterson, N.A.M. (1993) Loss of hypoxic pulmonary vasocon-triction in chronic pneumonia is not mediated by nitric oxide. Am. J. Physiol., 265, H1523–8.
Liu, S., Crawley, D.E., Barnes, P. J. and Evans, T.W. (1991) Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am. Rev. Respir. Dis., 143, 32–7.
Oka, M., Hasunuma, K., Webb, S.A. et al. (1993) EDRF suppresses an unidentified vasoconstriction mechanism in hypertensive rat lungs. Am. J. Physiol., 264, L587–97.
Bansal, V., Toga, H. and Usha Raj, J. (1993) Tone dependent nitric oxide production in ovine vessels in vitro. Respir. Physiol.93, 249–60.
Mazmanian, G.-M., Baudet, B., Brink, C. et al. (1989) Methylene blue potentiates vascular reactivity in isolated rat lungs. J. Appl. Physiol., 66, 1040–5.
Brashers, V.L., Peach, M. J. and Rose, C.E. Jr (1988) Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation. J. Clin. Invest.82, 1495–502.
Madden, M.C., Vender, R.L. and Friedman, M. (1986) Effect of hypoxia on prostacyclin production in cultured pulmonary artery endothelium. Prostaglandins, 31, 1049–62.
Voelkel, N.F., Gerber, J.G., McMurtry, I.F. et al. (1981) Release of vasodilator prostaglandin, P.G.I.2 from isolated rat lung during vasoconstriction. Cir. Res.48, 207.
Madden, J.A., Dawson, C.A. and Harder, D.R. (1985) Hypoxia-induced activation in small isolated pulmonary arteries from the cat. J. Appl. Physiol.59, 113–8.
Murray, T.R., Chen, L., Marshall, B.E. and Macarak, E. J. (1990) Hypoxic contraction of cultured pulmonary vascular smooth muscle cells. Am. J. Respir. Cell. Mol. Biol. Mol Biol, 3, 457–65.
Madden, J.A., Vadula, M.S. and Kurup, V.P. (1992) Effects of hypoxia and other vasoactive agents on pulmonary and cerebral artery smooth muscle cells. Am. Physiol.263, L384–93.
Harder, D.R., Madden, J.A. and Dawson, C. (1985) Hypoxic induction of Ca2 +-dependent action potentials in small pulmonary arteries of the cat. J. Appl. Physiol.59, 1389–93.
Jin, N., Packer, C.S. and Rhoades, R.A. (1992) Pulmonary arterial hypoxic contraction: signal transduction. Am. J. Physiol.263, L73–8.
Hoshino, Y., Obara, H., Kusunoki, M. et al. (1988) Hypoxic contractile response in isolated human pulmonary artery: role of calcium ion. J. Appl. Physiol.65, 2468–74.
Rodman, D.M., Yamaguchi, T., O’Brien, R.F. and McMurtry, I.F. (1989) Hypoxic contraction of isolated rat pulmonary artery. J. Pharmacol. Exp.248, 952–9.
McMurtry, I.F. (1985) Bay K8644 potentiates and A23187 inhibits hypoxic vasoconstriction in rat lungs. Am. Physiol.249, H741–6.
Salvaterra, C.G. and Goldman, W.F (1993) Acute hypoxia increases cytosolic calcium in cultured pulmonary arterial myocytes. Am. Physiol., 264; L323–8
Yuan, X.-J., Goldman, WF, Tod, ML et al. (1993) Hypoxia reduces potassium currents in cultured rat pulmonary but not mesenteric arterial myocytes, Am. J. Physiol., 264, L116–23.
Haynes, W.G. and Webb, D. J. (1993) The endothelin family of peptides: local hormones with diverse roles in health and disease? Clin. Sei, 84, 485–500.
Sirvio, M.L., Matsarinne, K., Saijonmaa, O. and Fyhrquist, F. (1990) Tissue distribution and half life of 125 I-endothelin in the rat: importance of pulmonary clearance. Biochem. Biophys. Res. Commun., 167; 1191–5.
Westcott, J.Y., Henson, J., McMurtry, I.F. and O’Brien, R.F. (1990) Uptake and metabolism of endothelin in the isolated perfused rat lung. Exp. Lung Res., 16 521–32.
Horgan, M. J., Pinheiro, J.M. and Malik, A.B. (1991) Mechanism of endothelin-1 induced pulmonary vasoconstriction. Circ. Res., 69; 157–64.
Wang, Y. and Coceani, F. (1992) Isolated pulmonary resistance vessels from fetal lambscontractile behavior and responses to indom-ethacin and endothelin-1. Circ. Res., 71; 320–30.
Lippton, H.L., Cohen, G.A., McMurtry, IF. and Hyman, A.L. (1991) Pulmonary vasodilation to endothelin isopeptides is mediated by potassium channel activation. J. Appl. Physiol., 70; 947–52.
Lippton, H.L., Hauth, T.A., Cohen, G.A. and Hyman, A.L. (1993) Functional evidence for different endothelin receptors in the lung. J. Appl. Physiol., 75; 38–48.
De Nucci, G., Thomas, R., D’Orleans-Juste, P. et al. Pressor effects of circulating endothelin are limited by its removal from the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl Acad. Sei. USA 85; 9797–800.
D’Orleans-Juste, P., Telemaque, S., Claing, A., et al. (1992) Human big-endothelin-1 and endothelin-1 release prostacyclin via the activation of ET1 receptors in the rat perfused lung. Br. J. Pharmacol., 105; 773–5.
Tod, M.L. and Cassin, S. (1992) Endothelin-1-induced pulmonary arterial dilation is reduced by Nw-nitro-L-arginine in fetal lambs. J. Appl. Physiol., 72; 1730–4.
Namiki, A., Hirata, Y., Ishikawa, M. et al. Endothelin-1 and endothelin-3-induced vasorelaxation via common generation of endothelium-derived nitric oxide. Life Sei., 50; 677
Crawley, D.E., Liu, S.F., Barnes, P. J. and Evans, T.W. (1992) Endothelin-3 is a potent pulmonary vasodilator in the rat. J. Appl. Physiol., 72; 1425–31.
Hirata, Y, Emori, T., Eguchi, S., et al. (1993) Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J. Clin. Invest., 91; 1367–73.
Inoue, A., Yanagisawa, M., Simura, S. et al. (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl Acad. Sei. USA, 86; 2863–7.
Sibbald, W. J., Paterson, N.A.M., Holliday, R.L. et al. (1978) Pulmonary hypertension in sepsis: measurement by the pulmonary arterial diastolic-pulmonary wedge pressure gradient and the influence of passive factors. Chest, 73; 583–91.
Snapper, J.R., Bernard, G.R., Hinson, et al. (1993). Endotoxemia-induced leukopenia in sheep — correlation with lung vascular permeability and hypoxemia but not with pulmonary hypertension. Am. Rey. Respir. Dis.127; 306–9.
Dehring, D. J., Lowery, B.D., Flynn, J. et al. (1983) Indomethacin improvement of septic acute respiratory failure in a porcine model. J. Trauma, 23; 725–9.
Winn, R., Harlan, J., Nadir, B. et al. (1983) Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin. J. Clin. Invest.72; 911–8.
Watkins, W.D., Huttemeier, P.C., Kong, D. and Peterson, M.B. (1982) Thromboxane and pulmonary hypertension following E. coli endotoxin infusion in sheep: effect of an imidazole derivative. Prostaglandins, 23; 273–85.
Matthay, M.A., Eschenbacher, W.L. and Goet-zel, E. J. (1984) Elevated concentrations of leu-kotriene D4 in pulmonary edema fluid of patients with the adult respiratory distress syndrome. J. Clin. Immunol, 4; 479–83.
Ratnoff, W.D., Matthay, M.A., Wong, M.Y.S. et al. (1988) Sulfïdopeptide-leukotriene peptidases in pulmonary edema fluid from patients with the adult respiratory distress syndrome. J. Clin. Immunol, 8; 250–8.
Bernard, G.R., Korley, V., Chee, P. et al. (1991) Persistent generation of peptido leukotrienes in patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis., 144, 263–7.
Coggeshall, J.W., Christman, B.W., Lefferts, P.L. et al. (1988) Effect of inhibition of 5-lipox-ygenase metabolism of arachidonic acid on response to endotoxemia in sheep. J. Appl. Physiol., 65; 1351–9.
Olson, N.C., Dobrowsky, R.T. and Fleisher, L.N. (1987) Hydroxyeicosatetraenoic acids are increased in bronchoalveolar lavage fluid of endotoxemic pigs. Prostaglandins, 34; 493–503.
Ogletree, M.L., Oates, J.A., Brigham, K.L. and Hubbard, W.C. (1982) Evidence for pulmonary release of 5-hydroxyeicosatetranoic acid (5-HETE) during endotoxemia in unanesthe-tized sheep. Prostaglandins, 23, 459–8.
Hagmann, W., Denzlinger, C. and Keppler, D. Production of peptide leukotrienes in endotoxin shock. FEBS Lett., 180; 309–13.
Ahmed, T., Wasserman, M.A., Muccitelli, R., et al. (1986) Endotoxin-induced changes in pulmonary hemodynamics and respiratory mechanics — role of lipoxygenase and cycloox-ygenäse products. Am. Rev. Respir. Dis.134; 1149–57.
Gross, D., Dahan, J.B., Landau, E.H. and Krausz, M.M. (1990) Effect of leukotriene inhibitor LY-171883 on the pulmonary response to Escherichia coli endotoxemia. Crit. Care Med., 18; 190–7.
Ahmed, T., Weichman, B., Wasserman, M.A. et al. (1988) Prevention and reversal of endotoxin-induced pulmonary hypertension by a leukotriene antagonist. Eur. Respir. J., 1; 145–52.
Hamasaki, Y., Mojarad, M., Saga, T. et al. (1984) Platelet-activating factor raises airway and vascular pressures and induces edema in lungs perfused with platelet free solution. Am. Rev. Respir. Dis.129; 742–6.
Christman, B.W., Lefferts, P.L., King, G.A. and Snapper, J.R. (1988) Role of circulating platelets and granulocytes in PAF-induced pulmonary dysfunction in awake sheep. J. Appl. Physiol.64; 2033–41.
Burhop, K.E., van der Zee, H., Bisios, R. et al. (1986) Pulmonary vascular responses to platelet-activating factor in awake sheep and the role of cyclooxygenase metabolites. Am, Rev. Respir. Dis., 134; 548–54.
Doebber, T.W., Wu, M.S., Robbins, J.C. et al. (1985) Platelet activating factor involvement in endotoxin-induced hypotension in rats: studies with PAF-receptor antagonist kadsur-enone. Biochem. Biophys. Res. Commun.127; 799–808.
Christman, B.W, Lefferts, P.L., Blair, I.A. and Snapper, J.R. (1990) Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep. Am. Rev. Respir. Dis., 142; 1271–8.
Sessler, C.N., Glauser, F.L., Davis, D. and Fowler, A.A.-III. Effects of platelet-activating factor antagonist SRI 63–441 on endotoxemia in sheep. J. Appl. Physiol., 65; 2624–31.
Hsueh, W., Gonzalez-Crussi, F. and Arroyave, J.L. (1986) Release of leukotriene C4 by isolated, perfused rat small intestine in response to platelet-activating factor. J. Clin. Invest.78; 108–14.
Mclntyre, T.M., Zimmerman, G.A. and Pre-scott, S.M. (1986) Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc. Natl Acad. Sei. USA, 83; 2304–8.
Morel, D.R., Lacroix, J.S., Hemsen, A. et al. (1989) Increased plasma and pulmonary lymph levels of endothelin during endotoxin shock. Eur. J. Pharmacol., 167; 427–8.
Pittet, J.F., Morel, D.R., Hemsen, A. et al. (1991) Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann. Surg., 213; 261–4.
Weitzberg, E., Lundberg, J.M. and Rudehill, A. (1991) Elevated plasma level of endothelin in patients with sepsis syndrome. Circ. Shock, 33; 222–7.
Druml, W., Steltzer, H., Waldhausl, W. et al. (1993) Endothelin-1 in adult respiratory distress syndrome. Am. Rev. Respir. Dis., 148; 1169–73.
Fink, M.P., MacVittie, T. J. and Casey, L.C. (1984) Inhibition of prostaglandin synthesis restores normal hemodynamics in canine hyperdynamic sepsis. Ann. Surg., 200; 619–26.
Dantzker, D.R., Brook, C. J., Dehart, P. et al. (1979) Ventilation-perfusion distributions in the adult respiratory distress syndrome. Am. Rev. Respir. Dis., 120; 1039–52.
Light, R.B., Mink, S.N. and Wood, L.D.H. (1981) Pathophysiology of gas exchange and pulmonary perfusion in pneumococcal lobar pneumonia in dogs. I. Appl. Physiol., 50; 524–30.
Graham, L.M., Vasil, A., Vasil, M.L. et al. (1990) Decreased pulmonary vasoreactivity in an animal model of chronic Pseudomonas pneumonia. Am. Rev. Respir. Dis., 142; 221–9.
Newman, J.H., Loyd, J.E., English, D.K. et al. (1983) Effects of 100% oxygen on lung vascular function in awake sheep. J. Appl. Physiol.54; 1379–86.
McCormack, D.G., Crawley, D., Barnes, P. J. and Evans, T.W. (1992) Bleomycin-induced acute lung injury in rats selectively abolishes hypoxic pulmonary vasoconstriction: evidence against a role for platelet-activating factor. Clin. Sel, 82, 259–64.
Martin, C.M., Yaghi, A., Sibbald, W. J. et al. (1993) Differential impairment of vascular reactivity of small pulmonary and systemic arteries in hyperdynamic sepsis. Am. Rev. Respir. Dis.148; 164–72.
Yaghi, A., Paterson, N.A.M. and McCormack, D.G. (1993) Nitric oxide does not mediate the attenuated pulmonary vascular reactivity of chronic pneumonia. Am. J. Physiol., 265; H943–8.
Crawley, D.E., Zhao, L., Giembycz, M.A. et al. (1992) Chronic hypoxia impairs soluble gua-nylyl cyclase-mediated pulmonary arterial relaxation in the rat. Am. J. Physiol., 263, L325–32.
Eddahibi, S., Adnot, S., Carville, C. et al. (1992) L-Arginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats. Am. J. Physiol., 263; L194–200.
Dinh-Xuan, A.T., Higenbottam, T.W., Clel-land, C.A. et al. (1991) Impairment of endo-thelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N. Engl. J. Med., 324; 1539–47.
Parratt, J.R. and Sturgess, R.M. (1975) E. coli endotoxin shock in the cat: treatment with indomethacin. Br. J. Pharmacol., 53; 485–8.
Light, R.B. (1986) Indomethacin and acetylsalicylic acid reduce intrapulmonary shunt in experimental pneumococcal pneumonia. Am. Rev. Respir. Dis., 134; 520–5.
Hanly, P., Sienko, A. and Light, R.B. (1987) Effect of cyclooxygenase blockade on gas exchange and hemodynamics in Pseudomonas pneumonia. J. Appl. Physiol., 63; 1829–36.
Heuer, H.O., Darius, H., Lohmann, H.F. et al. (1991) Platelet-activating factor type activity in plasma from patients with septicemia and other diseases. Lipids, 26; 1381–5.
Tracey, K. J., Stephen, F.L. and Cerami, A. (1988) Cachetin/TNFa in septic shock and septic adult respiratory distress syndrome. Am. Rev. Respir. Dis., 138; 1377–9.
Beasley, D., Cohen, R.A. and Levinsky, N.G. (1989) Interleukin-1 inhibits contraction of vascular smooth muscle. J. Clin. Invest.83; 331–5.
Hanly, P. J., Dobson, K., Roberts, D. and Light, R.B. (1987) Effect of indomethacin on arterial oxygenation in critically ill patients with severe bacterial pneumonia. Lancet i, 351–4.
Julou-Schaeffer, G., Gray, G.A., Fleming, I. et al. (1990) Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am. J. Physiol., 259; H1038–43.
Kilbourn, R.G. and Griffith, O.W. (1992) Overproduction of nitric oxide in cytokine-medi-ated and septic shock. J. Natl Cancer Inst., 84, 827–31.
Wright, C.E., Rees, D.D. and Moncada, S. (1992) Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res., 26; 48–57.
Auguet, M., Lonchampt, M.O., Delaflotte, S. et al. (1992) Induction of nitric oxide synthase by lipoteichoic acid from staphylococcus aureus in vascular smooth muscle cells. FEB S Lett., 297; 183–5.
Busse, R. and Mulsch, A. (1990) Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett., 275; 87–90.
Sato, K., Miyakawa, K., Takeya, M. et al. (1995) Immunohistochemical expression of inducible nitric oxide synthase (iNOS) in reversible endotoxic shock studied by a novel monoclonal antibody against rat iNOS. J. Leu-koc. Bioc, 57; 36–44
Horn, G., Grant, S., Wolfe, G. et al. (1995) Lipopolysaccharide-induced hypotension and vascular hyporeactivity in the rat: tissue analysis of nitric oxide synthase mRNA and protein expression in the presence and absence of dexamethasone, NG-monomethyl-L-arginine or indomethacin. J. Pharmacol. Exp. Ther. , 272, 452–9.
Holcroft, J.W., Vassar, M. J. and Weber, C. J. Prostaglandin E1 and survival in patients with the adult respiratory distress syndrome. Ann. Surg., 85; 371–8.
Melot, C., Lejeune, P., Leeman, M. et al. (1989) Prostaglandin E2 in the adult respiratory distress syndrome. Am. Rev. Respir. Dis.139; 106.
Bone, R.C., Slotman, G., Maunder, R. et al. (1989) Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Chest, 96, 114–9.
Sibbald, W. J., Driedger, A.A., McCallum, D. et al. (1986) Nitroprusside infusion does not improve biventricular performance in patients with acute hypoxemic respiratory failure. J. Crit. Care, 1, 197–203.
Melot, C., Naeije, R., Mois, P. et al. (1987) Pulmonary vascular tone improves pulmonary gas exchange in the adult respiratory distress syndrome. Am. Rev. Respir. Dis., 138, 1232–6.
Frosteil, C., Fratacci, M.D., Wain, J.C. et al. (1991) Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation, 83, 2038–47.
Rossaint, R., Falke, K. J., Lopez, F. et al. (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. Engl. J. Med., 328, 399–405.
Berger, J.I., Gibson, R.L., Redding, G. J. et al. (1993) Effect of inhaled nitric oxide during group B streptococcal sepsis in piglets. Am. Rev. Respir. Dis., 147, 1080–6.
Weitzberg, E., Rudehill, A. and Lundberg, J.M. (1993) Nitric oxide inhalation attenuates pulmonary hypertension and improves gas exchange in endotoxin shock. Eur. J. Pharmacol., 233, 85–94.
Abman, S.H., Kinsella, J.P., Schaffer, M.S. and Wilkening, R.B. (1993) Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmonary hypertension. Pediatrics, 92, 606–9.
Haydar, A., Mauriat, P., Pouard, P. et al. (1992) Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects. Lancet, 340, 8834–5.
Rich, G.F., Murphy, G.D., Roos, C.M. and Johns, R.A. (1993) Inhaled nitric oxide — selective pulmonary vasodilation in cardiac surgical patients. Anesthesiology, 78, 1028–35.
Walmrath, D., Schneider, T., Pilch, J. et al. (1993) Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet, 342, 961–2.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Paterson, N.A.M., McCormack, D.G. (1996). Pulmonary Vascular Control Mechanisms. In: Evans, T.W., Haslett, C. (eds) ARDS Acute Respiratory Distress in Adults. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3430-7_17
Download citation
DOI: https://doi.org/10.1007/978-1-4899-3430-7_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-56910-4
Online ISBN: 978-1-4899-3430-7
eBook Packages: Springer Book Archive